持久性植物状态的临床试验
总计11140个结果
-
Peking University People's HospitalShanghai iCELL Biotechnology Co., Ltd, Shanghai, China未知
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's Hospital完全的
-
Mehrdad Abedi, MDMillennium Pharmaceuticals, Inc.完全的
-
Gilead Sciences终止
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)终止
-
Instituto de Medicina Molecular João Lobo AntunesHospital de Santa Maria, Portugal; IPOFG Lisboa, Portugal; IPOFG Porto, Portugal未知
-
National Eye Institute (NEI)The Emmes Company, LLC终止
-
Andalusian Initiative for Advanced Therapies -...Iniciativa Andaluza en Terapias Avanzadas完全的免疫系统疾病 | 移植物抗宿主病 | Chronic and Expanded Graft Versus Host Disease西班牙
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.完全的
-
SCRI Development Innovations, LLCNovartis撤销
-
Russian Academy of Medical SciencesRussian Scientific Center of Surgery完全的
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital with Nanjing Medical University; Shenzhen People's Hospital; Xinqiao... 和其他合作者招聘中
-
Centro Specialistico Odontoiatrico, Rome招聘中
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Oncoimmune, Inc., a subsidiary of Merck & Co.,...National Cancer Institute (NCI); University of Michigan Rogel Cancer Center; Ohio State University 和其他合作者完全的Efprezimod Alfa (CD24Fc, MK-7110) 用于预防清髓性同种异体造血干细胞移植 (HSCT) 后急性移植物抗宿主病 (GVHD) 的 II 期试验 (MK-7110-002)白血病 | 造血干细胞移植 | 移植物抗宿主病美国
-
Alexion Pharmaceuticals终止
-
Ann & Robert H Lurie Children's Hospital of Chicago完全的
-
Ann & Robert H Lurie Children's Hospital of ChicagoAstex Pharmaceuticals, Inc.完全的
-
Newcastle UniversityFera Science; Institute For Agri-food Research and Innovation未知
-
Regimmune Corporation完全的
-
Prof. Dr. med. Ingo Eitel招聘中
-
CytoDyn, Inc.Amarex Clinical Research终止